Related Experiment Video
Updated: Mar 21, 2026
09:54
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
2.4K
[Lung Transplantation in Icelanders]
Laeknabladid
|May 20, 2016
Summary
Lung transplantation outcomes for Icelanders show survival rates comparable to larger centers, with chronic rejection and infections as primary complications. This study highlights the importance of close collaboration with transplant centers for optimal patient care.
Area of Science:
- Pulmonology
- Transplant Surgery
- Immunology
Background:
- Lung transplantation is a vital treatment for end-stage lung diseases, significantly improving quality of life.
- Common complications include infections and rejection, which can limit transplant feasibility.
- Key factors for successful lung transplantation involve careful patient selection and management of post-operative complications.
Purpose of the Study:
- To analyze the outcomes of lung transplantations performed on Icelandic patients.
- To evaluate survival rates, indications, and complications in this specific patient cohort.
- To assess the feasibility and effectiveness of lung transplantation for Icelandic patients with end-stage lung disease.
Main Methods:
- Retrospective analysis of 21 lung transplantations performed on Icelandic patients between February 1988 and January 2015.
- Data collection included demographics, underlying lung disease, transplantation type, immunosuppression, and complications from medical records.
- Statistical analysis focused on survival, rejection rates, and causes of mortality.
Main Results:
- The study included 21 patients (9 female, 11 male) with a mean age of 45. COPD was the most common indication for transplantation.
- Bilateral lung transplantation was the most frequent procedure. Rejection and infections were the most common complications, with 8 of 20 patients experiencing acute rejection and half experiencing chronic rejection.
- Median survival was 8.5 years, and the 5-year survival rate was 74%. Three of the six deceased patients died from chronic rejection.
Conclusions:
- Lung transplantation outcomes for Icelandic patients are comparable to those at larger international centers.
- Close cooperation between Icelandic pulmonologists and the transplanting center (Sahlgrenska hospital) is crucial for successful follow-up and management.
- Despite complications like rejection and infections, lung transplantation offers a viable option for improving survival and quality of life in selected Icelandic patients.
